Showing results (111-120 of 313) with videos related to
Sort By:
Pageof 32
Experimental and Therapeutic Medicine|November 9, 2012
Adverse effect of mild temperature hyperthermia combined with hexamethylenetetramine compared to its effect combined with tirapazamine in the treatment of solid tumorsShin-Ichiro Masunaga, Keizo Tano, Jun Nakamura, et al.International Journal of Radiation Biology|June 1, 2007
Analysis of Common Deletion (CD) and a novel deletion of mitochondrial DNA induced by ionizing radiationLu Wang, Yoshikazu Kuwahara, Li Li, et al.Journal of Biochemistry|October 17, 2012
Nucling, a novel protein associated with NF-κB, regulates endotoxin-induced apoptosis in vivoSun Mi Kim, Takashi Sakai, Huy Van Dang, et al.Journal of Cancer Research and Clinical Oncology|August 23, 2006
Dependency of the effect of a vascular disrupting agent on sensitivity to tirapazamine and gamma-ray irradiation upon the timing of its administration and tumor size, with reference to the effect on intratumor quiescent cellsShin-ichiro Masunaga, Hideko Nagasawa, Kenji Nagata, et al.Radiation Medicine|July 19, 2003
Effects of p53 status and wortmannin treatment on potentially lethal damage repair, with emphasis on the response of intratumor quiescent cellsShin-ichiro Masunaga, Akihisa Takahashi, Ken Ohnishi, et al.Journal of Radiation Research|December 1, 2010
An alternative mechanism for radioprotection by dimethyl sulfoxide; possible facilitation of DNA double-strand break repairGenro Kashino, Yong Liu, Minoru Suzuki, et al.Journal of Radiation Research|July 1, 2020
An attempt to improve the therapeutic effect of boron neutron capture therapy using commonly employed 10B-carriers based on analytical studies on the correlation among quiescent tumor cell characteristics, tumor heterogeneity and cancer stemnessShin-Ichiro Masunaga, Yu Sanada, Keizo Tano, et al.Journal of Radiation Research|October 26, 2012
Wortmannin efficiently suppresses the recovery from radiation-induced damage in pimonidazole-unlabeled quiescent tumor cell populationShin-Ichiro Masunaga, Yoshinori Sakurai, Hiroki Tanaka, et al.Journal of Radiation Research|February 10, 2023
The impact of TP53 status of tumor cells including the type and the concentration of administered 10B delivery agents on compound biological effectiveness in boron neutron capture therapyShin-Ichiro Masunaga, Yu Sanada, Takushi Takata, et al.Neuro-Oncology|May 13, 2021
Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-upSatoshi Takai, Masahiko Wanibuchi, Shinji Kawabata, et al.Pageof 32